Literature DB >> 19751713

Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism.

Juliana A Uzuelli1, Carlos A C Dias-Junior, Tatiane C Izidoro-Toledo, Raquel F Gerlach, Jose E Tanus-Santos.   

Abstract

BACKGROUND: The diagnosis of acute pulmonary thromboembolism (APT) and its severity is challenging. No previous study has examined whether there is a linear relation between plasma DNA concentrations and the severity of APT. We examined this hypothesis in anesthetized dogs. We also examined the changes in plasma DNA concentrations in microspheres lung embolization and whether the therapy of APT with nitrite could modify APT-induced changes in plasma DNA concentrations. In vitro DNA release from blood clots was also studied.
METHODS: APT was induced with autologous blood clots (saline, 1, 3, or 5 ml/kg) injected into the right atrium. A group of dogs received 300 microm microspheres into the inferior vena cava to produce similar pulmonary hypertension. Another group of dogs received 6.75 micromol/kg nitrite after APT with blood clots of 5 ml/kg. Hemodynamic evaluations were carried out for 120 min. DNA was extracted from plasma samples using QIAamp DNA Blood Mini Kit and quantified using Quant-iT PicoGreen dsDNA detection kit at baseline and 120 min after APT.
RESULTS: APT produced dose-dependent increases in plasma DNA concentrations, which correlated positively with pulmonary vascular resistance (P=0.002, r=0.897) and with mean pulmonary arterial pressure (P=0.006, r=0.856). Conversely, lung embolization with microspheres produced no significant changes in plasma DNA concentrations. While nitrite attenuated APT-induced pulmonary hypertension, it produced no changes in plasma DNA concentrations. Blood clots released dose-dependent amounts of DNA in vitro.
CONCLUSIONS: Cell-free DNA concentrations increase in proportion to the severity of APT, probably as a result of increasing amounts of thrombi obstructing the pulmonary vessels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751713     DOI: 10.1016/j.cca.2009.09.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Description of a strong relationship among total cell-free DNA levels, LDH values, AST values and platelet count in patients with HELLP syndrome.

Authors:  Pablo Stiefel; María L Miranda; Hada Macher; Luis M Beltran-Romero; Rocio Muñoz-Hernandez
Journal:  Hypertens Res       Date:  2017-03-23       Impact factor: 3.872

2.  Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy.

Authors:  Apostolos Zaravinos; Spiros Tzoras; Stavros Apostolakis; Kyriakos Lazaridis; Demetrios A Spandidos
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

3.  Analysis of Diacylglycerol Molecular Species in Cellular Lipid Extracts by Normal-Phase LC-Electrospray Mass Spectrometry.

Authors:  Thomas J Leiker; Robert M Barkley; Robert C Murphy
Journal:  Int J Mass Spectrom       Date:  2011-08-15       Impact factor: 1.986

4.  Effects of extracellular DNA on plasminogen activation and fibrinolysis.

Authors:  Andrey A Komissarov; Galina Florova; Steven Idell
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

5.  Cell-free DNA as a promising marker for risk stratification of pulmonary embolism.

Authors:  Evandro M Neto-Neves
Journal:  Crit Care       Date:  2013-11-19       Impact factor: 9.097

Review 6.  Emerging roles of Toll-like receptor 9 in cardiometabolic disorders.

Authors:  Sachiko Nishimoto; Daiju Fukuda; Masataka Sata
Journal:  Inflamm Regen       Date:  2020-07-21

7.  Circulating cell-free DNA as a potential marker in smoke inhalation injury.

Authors:  Yehiel Hayun; Yaron Shoham; Yuval Krieger; Eldad Silberstein; Amos Douvdevani; Dean Ad-El
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

8.  DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1.

Authors:  Genaro A Paredes-Juarez; Neha M Sahasrabudhe; Reina S Tjoelker; Bart J de Haan; Marten A Engelse; Eelco J P de Koning; Marijke M Faas; Paul de Vos
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

9.  Plasma NT-proBNP and Cell-Free DNA Concentrations after Prolonged Strenuous Exercise in Working Farm Dogs.

Authors:  H Hunt; N Cave; J Bridges; K Gedye; K Hill
Journal:  J Vet Intern Med       Date:  2017-12-02       Impact factor: 3.333

10.  Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension.

Authors:  Anna Hemnes; Alexander M K Rothman; Andrew J Swift; Lawrence S Zisman
Journal:  Pulm Circ       Date:  2020-11-18       Impact factor: 2.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.